HEALTH OF WOMAN. 2017.10(126):128–132

Гордеева Г. Д., Товстановская В. А., Тер-Тумасова А. Г.
Национальный медицинский университет имени А.А. Богомольца, г. Киев
Медицинский центр «ХЕЛСИ ЭНД ХЕППИ», г. Киев

В статье представлен обзор литературы, посвященной проблеме влияния фитоэстрогенов (ФЭ) на здоровье женщины в период климактерия. Рассматриваются аспекты их механизма действия. Приведены данные об эффективности использования препаратов, содержащих ФЭ, в комплексном лечении климактерических расстройств.
Ключевые слова: фитоэстрогены, климактерические расстройства у женщин.

Литература

1. Ахтямов С.Н., Гетлинг З.М., Бутов Ю.С. (2004). Старение кожи. Экспериментальная и клиническая дерматокосметология. 5: 2–10.

2. Барабой В.А. (2009). Изофлавоны сои: биологическая активность и применение. Биотехнология. 2; 3: 44–54.

3. Ботоева Е.А. (2010). К вопросу о фитоэстрогенах. Бюллетень ВСНЦ СО РАМН. 2(72): 234–237.

4. Ботоева Е.А., Убеева И.Т. (2009). Биологическая роль фитоэстрогенов. Вестник бурятского госуниверситета. 12.

5. Бухарина Е. (2007). Фитоэстрогены – мнение гінеколога. J.Les Nouvelles Esthetic. 1: 10–17.

6. Здоровье женщин и менопауза. Пер.с англ. (2004). М.: ГЭОТАР-МЕД: 528.

7. Зотов О.С., Поступаленко О.В., Верещако Р.И. (2015). Фітоестрогени: молекулярні механізми дії в онкологічному аспекті. Клінічна ендокринологія та ендокринна хірургія. 3(51): 7–16.

8. Кузнецова И.В., Успенская Ю.Б. (2013). Применение фитоэстрогенов у женщин в период менопаузального перехода и постменопаузе. Эффективная фармакотерапия. 6(55): 44–51.

9. Мальцева Л.И. (2009). Фитоэстрогены сои в лечении климактерического синдрома. Практическая медицина. 2: 119–121.

10. Марголина А.А., Эрнандес Е.И. (2001). Новая косметология. М.: Косметика и медицина: 204.

11. Мирзоева П.Н., Матушевская Е.В., Зайдиева Я.З. (2009). Топические фитоэстрогены в коррекции инволюционных изменений кожи. Вестн. дерматол. и венерол. 3: 87–92.

12. Остеопороз. Диагностика, профилактика и лечение. Клинические рекомендации. (2010). Под ред. Беневоленской Л.И., Лесняк О.М. М.: ГЭОТАР-Медиа.

13. Сметник В.П. (2001). Биология и патобиология климактерия. В кн. «Руководство по климактерию». М.: МИА: 9–35.

14. Сметник В.П. (2006). Альтернатива заместительной гормонотерапии. В кн. «Медицина климактерия». М.: ООО Изд-во Литера: 166–86.

15. Сметник В.П. (2009). Приливы: загадка климактерия. Климактерий. Медицинский научно-реферативный журнал Российской ассоциации по менопаузе. 1: 3–4.

16. Сметник В.П., Ильина Л.М. (2009). Роль половых гормонов в развитии метаболических расстройств у женщин в пери- и ранней постменопаузе. Климактерий. 1: 8–13.

17. Тарумов Р.А., Гребенюк А.Н., Башарин В.А., Ковтун В.Ю. (2014). Биологические свойства фитоэстрогена генистеина. Медицина экстремальных ситуаций. 2(48): 55–68.

18. Тихомиров А.Л. (2008). Изофлавоны сои в лечении климактерического синдрома. Гинекология. 2: 44–46.

19. Турова Е.А., Королевская Л.И. (2008). Изофлавоны в коррекции возрастных изменений кожи. Гинекология. 5: 80–83.

20. Шишкова В.Н. (2013). Проблемы старения и заместительная гормональная терапия у женщин в постменопаузе. Российский вестник акушера-гинеколога. 2: 420–447.

21. Agnusdei D, Comston J. 2000. SERMs — A novel Option to Maintain Health in the Postmenopause. M. Dutitz. 161:21.

22. Atkinson C, Compston J, Day NE. 2004. The effects phytoestrogen isoflavones on bone density in women: a double-blind, randomized-controlled trial. Am J Clin Nutr. 79:326–333. https://doi.org/10.1093/ajcn/79.2.326; PMid:14749241

23. Bolanos R, Del Castillo A, Francia J. 2010. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Menopause. 17;3:660–666. https://doi.org/10.1097/gme.0b013e3181cb4fb5

24. Brincat MP, Baron Y, Galea R. 2005. Estrogens and the skin. Am. Climacteric. 8:110–123. https://doi.org/10.1080/13697130500118100; PMid:16096167

25. Brown S, Rosen SJ. 2003. Osteoporosis. Med Clin North Am. 87:1039–1063. https://doi.org/10.1016/S0025-7125(03)00065-8

26. Brueggemeier RW, Gu X, Mobley JA et al. 2001. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism. Ann.N.Y. Acad.Sci. 948:51–66. https://doi.org/10.1111/j.1749-6632.2001.tb03986.x; PMid:11795395

27. Calleja-Agius J, Brincat MP. 2011. The effect of menopause on the skin and of the connective tiissues. Gynecol Endocrinol. 28(4):273–277. https://doi.org/10.3109/09513590.2011.613970; PMid:21970508

28. Calleja-Agius J, Muscat-Baron Y, Brincat MP. 2007. Skin ageing. Review Menopause International. 13:60–64. https://doi.org/10.1258/175404507780796325; PMid:17540135

29. Campbell MJ, Woodside JV, Honour JW et al. 2004. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. European J of Clinical Nutrition. 58:173–179. https://doi.org/10.1038/sj.ejcn.1601764; PMid:14679383

30. Chan MY, Wai Man G, Chen ZY et al. 2007. Oestrogen receptor alpha is required for biochanin A-induced apolipoprotein A-1 mRNA expression in HepG2 cells. Br. J. Nutr. 98;3:534–539. https://doi.org/10.1017/S0007114507750857; PMid:17532863

31. Chen YM, Ho SC, Lam SS et al. 2003. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J.Clin Endocrinol Metabol. 88:4740–4747. https://doi.org/10.1210/jc.2003-030290; PMid:14557449

32. Dai Q, Shu XO, Jin F. 2001. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer. 85:372–378. https://doi.org/10.1054/bjoc.2001.1873; PMid:11487268 PMCid:PMC2364075

33. Dechaud H, Ravard C, Claustrat F et al. 1999. Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids. 64:328–34. https://doi.org/10.1016/S0039-128X(98)00114-7

34. Djuric Z, Chen G, Doenge DR et al. 2001. Effect of soy isoflavone supplementation on oxidative stress in men and women. Cancer Lett. 172:1–6. https://doi.org/10.1016/S0304-3835(01)00627-9

35. Fang M, Chen D, Sun Y et al. 2005. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta and MGMT genes by genistein and other isoflavones from soy. Clinical Cancer Research. 11:7033–7041. https://doi.org/10.1158/1078-0432.CCR-05-0406; PMid:16203797

36. Gencel VB, Benjamin MM, Bahou SN et al. 2012. Vascular effect of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease. Mini Rev. Med. Chem. 12(2):149–174. https://doi.org/10.2174/138955712798995020; PMid:22070687 PMCid:PMC3288319

37. Green RA. 1999. Measurement of estrogens effect on the brain using modern imaging techniques. Menopausal Med. 7:9–12.

38. Hill DA, Hill SR. 2010. Counseling patient about hormone therapy and alternatives for menopausal symptoms. Am. Fam. Physician. 82;7:801–807. PMid:20879703

39. Hillman GG et al. 2011. Soy isoflavones radio-sensitize lung cancer while mitigating normal tissue injury. Radiotherapy and Oncоlogy. 13;2:329–336. https://doi.org/10.1016/j.radonc.2011.10.020; PMid:22079530 PMCid:PMC3229191

40. Hwang J, Wang J, Morazzoni P et al. 2003. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. J.Biol.Med. 34:1271–1282. https://doi.org/10.1016/S0891-5849(03)00104-7

41. Jordan VC. 2001. The past, present and future of selective estrogen receptor modulation. New York Acad Sci. 949:72–79. https://doi.org/10.1111/j.1749-6632.2001.tb04004.x

42. Kaldas RS, Hughes GL. 2009. Reproductive and general effects of phytoestrogens in mammals. Reprod.Toxicol. Rev. 3:81–89. https://doi.org/10.1016/0890-6238(89)90042-7

43. Kritz-Silverstein D, Von Muhlen D, Barret-Connor E et al. 2003. Isoflavones and cognitive function in older women: the Soy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause. 10:196–202. https://doi.org/10.1097/00042192-200310030-00004; PMid:12792289

44. Le Bail JC, Champavjer Y, Chulia AJ et al. 2000. Effects of phytoestrogens on aromatase, 3 beta and 17 beta-hydroxysteroid dehydrogenase activites and human breast cancer cells. Life Sci. 66:1282–1291. https://doi.org/10.1016/S0024-3205(00)00435-5

45. Li Z, Zhang Z, Hill D et al. 2005. Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranscriptional levels. Cancer Research. 65;18:8200–8208. https://doi.org/10.1158/0008-5472.CAN-05-1302; PMid:16166295

46. Mahadi GB. 2005. Soy isoflavones cause endometrial hyperplasia? Nutr.Revs. 63:392–397. https://doi.org/10.1111/j.1753-4887.2005.tb00376.x

47. Markaverich BM. 2005. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. Environ. Helth Persр. 103:574–581. https://doi.org/10.1289/ehp.95103574

48. Milan MT, Dotlic J, Maricic S. 2009. Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. J. Obstet. Gynaecol. Res. 35;6:1091–1095. https://doi.org/10.1111/j.1447-0756.2009.001059.x; PMid:20144173

49. Oseni T, Patel R, Pyle J et al. 2008. Selective estrogen receptor modulators and phytoestrogenes. Planta Med. 74;13:1656–1665. https://doi.org/10.1055/s-0028-1088304; PMid:18843590 PMCid:PMC2587438

50. Ohmichi M, Tasaka K, Kurachi H et al. 2005. Molecular mechanism of action of selective estrogen receptor modulator in target tissues. Endocr. J. 52;21:61–67. https://doi.org/10.1507/endocrj.52.161

51. Pietras RJ, Weinberg OK. 2005. Antiangiogenic steroids in human cancer therapy. Evidence-based Complementary and Alternative Medicine. 13;1:49–57. https://doi.org/10.1093/ecam/neh066; PMid:15841278 PMCid:PMC1062159

52. Pinell SR. 2003. Cutaneous photodamage, oxidative stress and topical antioxidant protection. J Am Acad Dermatol. 48;1:1–19. https://doi.org/10.1067/mjd.2003.16; PMid:12522365

53. Pines A. 2011. Vasomotor symptoms and cardiovascular disease risk. Climacteric. 14:535–536. https://doi.org/10.3109/13697137.2011.599058; PMid:21848496

54. Rice S, Whitehead SA. 2008. Phytoestrogens oestrogen synthesis and breast cancer. J. Steroid. Biochem. Mol. Biol. 108:186–195. https://doi.org/10.1016/j.jsbmb.2007.09.003; PMid:17936616

55. Rice S, Mason HD, Whitehead SA. 2006. Phytoestrogens and their low dose combinations inhibit mRNA exspression and activity of aromatase in human granulosa-luteal cells. J. Steroid Biochem Mol Biol. 101(4–5):216–225. https://doi.org/10.1016/j.jsbmb.2006.06.021; PMid:16965912

56. Rissman EF. 2006. Roles of oestrogen receptors alpha and beta in behavioural neuroendocrinology. J. Neuroendocrinol. 20:873–879. https://doi.org/10.1111/j.1365-2826.2008.01738.x; PMid:18601711 PMCid:PMC2667101

57. Robb EL, Page MM, Wiens BE et al. 2008. Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem.Biophys. Res. Commun. 367:406–417. https://doi.org/10.1016/j.bbrc.2007.12.138; PMid:18167310

58. Rimbach G, Boesch-Saadatmandi C, Frank J. 2008. Dietary isoflavones in the prevention of cardiovascular disease – a molecular perspective. Food. Chem. Toxicol. 46:1308–1319. https://doi.org/10.1016/j.fct.2007.06.029; PMid:17689850

59. Roussow JE, Anderson GL, Prentice RL. 2002. Writing group for the womens health initiative investigators. Risks and benefits of estrogen + progestin in healthy postmenopausal women. JAMA. 228:321–333.

60. Shutt DA. 2006. The effect of plant oestrogens on animal reproduction. Endeavor. 35:110–113. https://doi.org/10.1016/0160-9327(76)90004-1

61. Simoncini T, Fomari L, Mannella P. 2005. Activation of nutric oxide synthesis in human endothelial cells by red clover extracts. Menopause. 12;1:69–77. https://doi.org/10.1097/00042192-200512010-00013

62. Taku K, Melby MK, Kronenberg F et al. 2012. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and metа-analysis of randomized controlled trials. Menopause. 19;7:776–790. https://doi.org/10.1097/gme.0b013e3182410159; PMid:22433977

63. Tempfer CB, Bentz EK, Leodolter S et al. 2007. Phytoestrogens in clinical practice: a review of the literature. Fertil. Steril. 87;6:1243–1249. https://doi.org/10.1016/j.fertnstert.2007.01.120; PMid:17490659

64. Tsai SA, Stefanick ML, Stafford RS. 2011. Trends in menopausal hormone therapy use of US office-based physicians 2000–2009. Menopause. 18;4:385–392. https://doi.org/10.1097/gme.0b013e3181f43404; PMid:21127439 PMCid:PMC3123410

65. Verdier-Servrain S, Bonter F, Gilchrest B. 2006. Bioligy of estrogens in skin: implications for skin aging. Experimental Dermatology. 15:83–94. https://doi.org/10.1111/j.1600-0625.2005.00377.x; PMid:16433679

66. Walker SE, Register TS, Appt SE et al. 2008. Plasma lipid-dependent and –independent effects of dietary soy protein and social status on atherogenesis in premenopausal monkeys: implications for postmenopausal atherosclerosis burden. Menopause. 15(4):256–263. https://doi.org/10.1097/gme.0b013e3181612cef

67. Warri A, Saarinen N, Makela S, Hilakivi-Clarke L. 2008. The role of early life genistein exposures in modifying breast cancer risk. Br.J.Cancer. 98:1485–1493. https://doi.org/10.1038/sj.bjc.6604321; PMid:18392054 PMCid:PMC2391102

68. Witztum JL, Steinberg D. 2001. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc. Med. 11:93–102. https://doi.org/10.1016/S1050-1738(01)00111-6

69. Whitten PL, Russel E, Naftolin F. 2002. Effects of normal, human-concentration, phytoestrogen diet on rat uterine growth. Steroids. 57:98–102. https://doi.org/10.1016/0039-128X(92)90066-I

70. Xiao CW. 2008. Health effect of soy protein and isoflavones in humans. J.Nutr. 138:1244–1249. https://doi.org/10.1093/jn/138.6.1244S